ETC
ALXN

Exchange Traded Concepts’s Alexion Pharmaceuticals ALXN Stock Holding History

Exchange Traded Concepts’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-3,645
Closed -$670K – 1297
2021
Q2 		$670K Buy
3,645
+459
+14% +$78.8K 0.02% 409
2021
Q1 		$487K Sell
3,186
-20,525
-87% -$3.17M 0.02% 525
2020
Q4 		$3.71M Buy
23,711
+14,567
+159% +$1.87M 0.17% 93
2020
Q3 		$1.05M Buy
9,144
+5,954
+187% +$642K 0.06% 160
2020
Q2 		$358K Sell
3,190
-132
-4% -$14K 0.06% 266
2020
Q1 		$298K Buy
3,322
+1
+0% +$98 0.16% 177
2019
Q4 		$359K Buy
+3,321
New +$355K 0.08% 152

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $434M AUM 44.19% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

Exchange Traded Concepts's ALXN Position: Q3 2021 in Review

Exchange Traded Concepts sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 3,645 shares — an estimated $670K sold.

Exchange Traded Concepts first reported a position in ALXN in Q4 2019 and held it in 7 quarters. The position peaked at $3.71M in Q4 2020. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Exchange Traded Concepts reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Exchange Traded Concepts sold 3,645 Alexion Pharmaceuticals shares in Q3 2021, an estimated $670K.
  • Exchange Traded Concepts first reported a position in Alexion Pharmaceuticals in Q4 2019 and held it in 7 quarters.
  • Exchange Traded Concepts's Alexion Pharmaceuticals position peaked at $3.71M in Q4 2020.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Exchange Traded Concepts's 13F filing for Q3 2021, filed 18 Oct 2021.